| RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases L Halász, Z Karányi, B Boros-Oláh, T Kuik-Rózsa, É Sipos, É Nagy, ... Genome research 27 (6), 1063-1073, 2017 | 93 | 2017 |
| TRPA1 deficiency is protective in cuprizone‐induced demyelination—A new target against oligodendrocyte apoptosis É Sághy, É Sipos, P Ács, K Bölcskei, K Pohoczky, A Kemeny, Z Sandor, ... Glia 64 (12), 2166-2180, 2016 | 61 | 2016 |
| First report from the German COVID-19 autopsy registry S von Stillfried, RD Bülow, R Röhrig, P Boor, J Böcker, J Schmidt, ... The Lancet Regional Health–Europe 15, 2022 | 54 | 2022 |
| Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice G Kriszta, É Sághy, M Payrits, É Sipos, A Vranesics, Z Berente, ... Journal of Neuroimmunology 320, 1-10, 2018 | 52 | 2018 |
| Quantitative comparison of primary cilia marker expression and length in the mouse brain É Sipos, S Komoly, P Ács Journal of Molecular Neuroscience 64, 397-409, 2018 | 50 | 2018 |
| Heterogeneous catalytic asymmetric hydrogenation of the C= C bond A Tungler, E Sipos, V Hada Current Organic Chemistry 10 (13), 1569-1583, 2006 | 48 | 2006 |
| Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin–GnRH-III bioconjugates R Hegedüs, M Manea, E Orbán, I Szabó, É Kiss, É Sipos, G Halmos, ... European journal of medicinal chemistry 56, 155-165, 2012 | 44 | 2012 |
| Comparative in vitro biological evaluation of daunorubicin containing GnRH‐I and GnRH‐II conjugates developed for tumor targeting I Szabó, S Bősze, E Orbán, É Sipos, G Halmos, M Kovács, G Mező Journal of Peptide Science 21 (5), 426-435, 2015 | 28 | 2015 |
| Asymmetric heterogeneous catalytic hydrogenation; is it a useful tool for the synthetic organic chemist? A Tungler, É Sípos, V Háda Arkivoc 7, 223-242, 2004 | 20 | 2004 |
| Solvent and support effects in enantioselective hydrogenation of isophorone with (s)-α,α -diphenyl-2-pyrrolidinemethanol modified palladium É Sípos, A Tungler, I Bitter Reaction Kinetics and Catalysis Letters 79, 101-109, 2003 | 16 | 2003 |
| AT; Samant, PV; Figueiredo É Sípos, G Fogassy J. Mol. Catal. A 212, 245, 2004 | 15 | 2004 |
| High viral loads: what drives fatal cases of COVID-19 in vaccinees?–an autopsy study K Hirschbühl, T Schaller, B Märkl, R Claus, E Sipos, L Rentschler, ... Modern Pathology 35 (8), 1013-1021, 2022 | 14 | 2022 |
| Stroma AReactive Invasion Front Areas (SARIFA)—a new easily to determine biomarker in colon cancer—results of a retrospective study B Martin, B Grosser, L Kempkens, S Miller, S Bauer, C Dhillon, BM Banner, ... Cancers 13 (19), 4880, 2021 | 13 | 2021 |
| Effect of pretreatment of the catalyst and catalyst-modifier system in the enantioselective hydrogenation of isophorone É Sípos, A Tungler Reaction Kinetics and Catalysis Letters 80, 365-373, 2003 | 13 | 2003 |
| Alterations in natural killer cells in colorectal cancer patients with Stroma AReactive Invasion Front Areas (SARIFA) NG Reitsam, B Märkl, S Dintner, E Sipos, P Grochowski, B Grosser, ... Cancers 15 (3), 994, 2023 | 11 | 2023 |
| The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma K Fodor, N Dobos, A Schally, Z Steiber, G Olah, E Sipos, L Szekvolgyi, ... Oncotarget 11 (2), 175, 2020 | 11 | 2020 |
| Impaired dendritic cell homing in COVID-19 L Borcherding, AS Teksen, B Grosser, T Schaller, K Hirschbühl, R Claus, ... Frontiers in medicine 8, 761372, 2021 | 10 | 2021 |
| Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma E Sipos, A Treszl, Z Steiber, G Mehes, N Dobos, K Fodor, G Olah, ... Oncology reports 37 (4), 1927-1934, 2017 | 9 | 2017 |
| Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines E Sipos, N Dobos, D Rozsa, K Fodor, G Olah, Z Szabo, L Szekvolgyi, ... OncoTargets and therapy, 933-941, 2018 | 8 | 2018 |
| Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152) G Oláh, N Dobos, G Vámosi, Z Szabó, É Sipos, K Fodor, K Harda, ... European journal of pharmaceutical sciences 123, 371-376, 2018 | 6 | 2018 |
